Fungal infection in patients with Alzheimer's disease

Ruth Alonso1, Diana Pisa1, Ana Isabel Marina1

  • 1Centro de Biología Molecular Severo Ochoa CSIC-UAM, C/ Nicolás Cabrera, 1 Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.

Insights

This study found fungal proteins and DNA in Alzheimer's disease (AD) brains, suggesting a potential fungal infection link to AD. Further research is needed to explore if fungi are a risk factor or cause of this neurodegenerative disease.

Area of Science:

  • Neuroscience
  • Mycology
  • Pathology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing dementia, characterized by amyloid plaques and neurofibrillary tangles.
  • Current understanding of AD etiology is incomplete, with research exploring various contributing factors beyond genetics and aging.

Purpose of the Study:

  • To investigate the presence and detectability of fungal infection in brain samples from Alzheimer's disease patients.
  • To identify fungal species and macromolecules within the brain tissue of individuals with AD.

Main Methods:

  • Proteomic analysis was employed to detect fungal proteins in AD brain samples.
  • Polymerase Chain Reaction (PCR) and DNA sequencing were used to identify fungal species present in the brain tissue.

Main Results:

  • Compelling evidence of fungal proteins was found in brain samples from Alzheimer's disease patients.
  • PCR and DNA sequencing identified a variety of fungal species in the brain samples, with variations depending on the patient and tissue.
  • Fungal macromolecules were demonstrably detected in brain tissue from AD patients.

Conclusions:

  • These findings represent the first evidence of detectable fungal infection in brain samples from Alzheimer's disease patients.
  • The study discusses the potential role of fungal infection as a risk factor or contributing etiological cause of Alzheimer's disease.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782